Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px
All >

Deals > Southern Europe & Israel

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Southern Europe & Israel or involving organisations from these regions.

Total search results: 651 | Ordered by Date (descending)
1 2 3 4 5 6 7  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Rocket Pharmaceuticals–MolMed: gene therapy, 201903– collab expansion developm + manufacture of lentiviral vectos by MolMed for three new indications 2019-03-13
SOM Biotech–SEVERAL: investment, 201903 financing round €7m led by European family holding 2019-03-07
BiomX–BPCE: investment, 201902 financing round Series B totalling $32m incl existing + co-lead investor Seventure Health for Life Capital fund 2019-02-20
BiomX–MacDougall Biomedical Communications: public relations, 201902 service existent by MacDougall 2019-02-20
BiomX–SEVERAL: investment, 201902 financing round Series B $32m led by existing investors OrbiMed + JJDC + Takeda Ventures et al 2019-02-20
Grifols–Rigel: fostamatinib, 201901– collab + license $30m upront + $297.5m milestones + royalties all indications in Europe + Turkey 2019-01-23
Medison Pharma–Alnylam: RNAi therapeutics, 201901– commcercialisation excl of Onpattro + other RNAi drugs from Alnylam in Israel 2019-01-21
UroGen–JPMorgan Chase: investor conference, 201901 supply service UroGen Pharma presents at JP Morgan Healthcare Conference 2019 2019-01-10
Senolytic Therapeutics–Life Biosciences: investment, 201901 acquisition of Senolytic by Life Biosciences 2019-01-09
Altheia Science–SEVERAL: investment, 201812 financing round Series A final closing €7.7m ($8.3m) bringing total round to €17m ($19.3m) 2018-12-19
Mestrelab Research–Bruker Corp: investment, 201812 acquisition of majority share €na by Bruker incl strateg collab + partnership 2018-12-13
JnJ–BiomX: biomarker discovery, 201812– collab using XMarker microbiome-based marker discovery platform for IBD therapeutics PDx 2018-12-12
Cassiopea–Hopp Group: investment, 201812 existent investment dievini Hopp owns 1% of Cassiopea SpA 2018-12-05
Cosmo Pharmaceuticals–Hopp Group: investment, 201812 existent investment dievini Hopp owns 5% of Cosmo SpA 2018-12-05
Oryzon Genomics–Citigroup: investor conference, 201812 supply service Oryzon attends Citi Global Healthcare Conference NY 2018-12-05
Lonza–Chaim Sheba Medical Center: cell therapy manufacturing technology, 201811 collab existent to evaluate + test Cocoon technology 2018-11-19
Cadent Therapeutics–Clal Industries: investment, 201811 financing round Series B totalling $40m incl co-investor Clal Biotechnology Industries 2018-11-15
Oryzon Genomics–Leucadia: investor conference, 201811 supply service Oryzon attends Jefferies London Healthcare Conference 2018 2018-11-14
Newron–EU (govt): credit, 201810– EIB/EFSI grant up to €40m to develop new CNS drugs 2018-10-30
Galecto Biotech–Ysios Capital: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor Ysios Capital 2018-10-26
Gamida Cell–SEVERAL: investment, 201810 IPO $50m+$7.5m with 6.25m+937.5k ordinary shares at $8/sahre at Nasdaq Global Market 2018-10-26
Oryzon Genomics–SEVERAL: investment, 201810 private placement €13m w 4.96m new common shares at €2.62/share 2018-10-26
Minoryx–SEVERAL: investment, 201809 financing round Series B €21.3m led by Fund+ with SFPI + SRIW + Sambrinvest + all Series A investors 2018-09-26
Altheia Science–SEVERAL: investment, 201809 financing round Series A 1st closing €9.3m ($11m) incl AurorA-TT + private investors 2018-09-25
Almirall–Evotec: drug discovery services, 201809– collab r+d therapies for dermatological diseases 2018-09-17
Menarini–Lunaphore: staining technology, 201809– collab Menarini Diagnostics to market LabSat Frozen tissue staining solution 2018-09-09
Grifols–EU (govt): credit, 201809–2028 loan €85m from European Investment Bank 2018-09-07
Merck (DE)–GlucoMe: digital health, 201808– collab digital diabetes management project in Vietnam 2018-08-22
Molecular Discovery–Lead Molecular Design: mass spectrometry s/w, 201808 distribution existent of MetaSite + MassMetaSite et al by Molecular Discovery 2018-08-04
Laboratorios Ecosur–Eurofins: investment, 201807 acquisition of Ecosur by Eurofins 2018-07-27
Dynacure–Pontifax: investment, 201807 financing round totalling €47m incl co-investor Pontifax 2018-07-06
Pharma Omnium–NuPharm: investment, 201807 acquisition €na of Laboratoire Biodim from Pharma Omnium 2018-07-03
Algenex–Cleon Capital: investment, 201807–201903 financing round Series B totalling €4m incl co-lead investor Cleon Capital 2018-07-01
Algenex–SEVERAL: investment, 201807–201903 financing round Series B €4m led by Cleon Capital + Vita Advisory 2018-07-01
Algenex–VitaTech: investment, 201807–201903 financing round Series B totalling €4m incl co-lead investor Vita Advisory 2018-07-01
GSK–MolMed: lentiviral vectors, 201807–202106 collab 3y developm + manufacture of lentiviral vectors by MolMed for GSK oncology programme 2018-07-01
Galmed–LifeSci: public relations, 201806 service existent by LifeSci Advisors 2018-06-19
Galmed–SEVERAL: investment, 201806 public offering $75m+$11.25m with 5m+750k ordinary shares at $15/share 2018-06-18
Bohui–Aviv Analytical: mass spectrometry software, 201806– supply TAMI molecular identifcation s/w now available for expression CMS 2018-06-04
Lunaphore–Vitro (ES): in situ hybridisation, 201805– collab developm ISH protocols for RNA + DNA targets in tissue 2018-05-24
Bionure–Alta Partners: investment, 201805 financing round Series A totalling €4m incl lead investor Alta Life Sciences 2018-05-16
Bionure–SEVERAL: investment, 201805 financing round Series A €4m led by Alta Life Sciences 2018-05-16
Alfatest (IT)–Applied Photophysics: analytical instruments, 201805– distribution of Chirascan CD + SX stoppe-flow systems in Italy by Alfatest 2018-05-15
Paralab (PT)–Applied Photophysics: analytical instruments, 201805– distribution of Chirascan CD + SX stoppe-flow systems in ES +PT by Paralab 2018-05-15
Recipharm–Hadassah (HMO): drug development services, 201805– collab combined offering of clinical + biological + chemical services Hadasit 2018-05-15
NovellusDx–SEVERAL: investment, 201804 financing round $6m incl investors Helsinn + BCIF + Windham Venture Partners 2018-04-30
EryDel–Genextra: investment, 201804 financing round totalling €26.5m incl existing + co-investor Genextra SpA 2018-04-24
EryDel–Innogest SGR: investment, 201804 financing round totalling €26.5m incl existing + co-investor Innogest SGR 2018-04-24
EryDel–SEVERAL: investment, 201804 financing round €26.5m led by Sofinnova Partners + incl Genextra + Innogest SGR 2018-04-24
EryDel–Sofinnova: investment, 201804 financing round totalling €26.5m inc lead investor Sofinnova Partners 2018-04-24
DiaMan–GlucoMe: digital health, 201804– collab product integration of GlucoMe + DiaMan products + marketing in Central America by DiaMan 2018-04-17
AstraZeneca–Compugen: antibody cancer drug, 201804– license $10m upfront + $200m milestones + royalties developm bi-/multi-specific ABs to MedImmune 2018-04-02
Reig Jofré–LeanBio: biosimilars, 201803– collab founding of joint venture Syna Therapeutics to develop biosimilars 2018-03-23
Aton–Grifols: investment, 201803– acquisition 100% of Haema for €220 on a debt free basis by Grifols from Aton GmbH 2018-03-20
PixCell Medical–EU (govt): grant, 201803 Horizon 2020 SME €2.5m grant for commerialization of HemoScreen blood analyzer 2018-03-14
Compugen–Cowen: investor conference, 201803 supply service Compugen presents at Cowen & Co Annual Health Care Conference 2018 2018-03-13
Compugen–Burns McClellan: public relations, 201803– service existent investor relations by Burns McClellan 2018-03-08
Deinove–Naicons: antibiotics drug discovery, 201803– collab incl access to strain bank of Naicons 2018-03-08
Compugen–JSR Corp: cell line development, 201803– license to use Selexis’ SUREtechnology for developm of cancer antibody drugs incl COM701 2018-03-07
MolMed–Miltenyi Biotec: cell therapy manufacturing technology, 201804 supply use of CliniMACS Prodigy for GMP production of Zalmoxis 2018-02-26
ABAC Therapeutics–SEVERAL: investment, 201802 financing round Series A €16m led by Pontifax + incl GHSF + Caixa Capital Risc + Debiopharm + Ferrer 2018-02-15
STAT-Diagnostica–Qiagen: investment, 201801 acquisition $147m upfront cash + $44m milestones of STAT-Dx by Qiagen 2018-01-31
BiomX–JSR Corp: phage therapy, 201801– license to bacterial targets for IBD treatment PX002 from JSR Corp/Keio Univ 2018-01-29
BIA Separations–Zyme Communications: public relations, 201801 service existent by Zyme 2018-01-17
Intelligent Pharma–Mind the Byte: investment, 201801 acquisition €na 100% of Intelligent Pharma by Mind the Byte 2018-01-11
Mind the Byte–SEVERAL: investment, 201801– financing round €3m (1/3 of company) to finance acquisition of Intelligent Pharma PLANNED 2018-01-11
Arcturus Therapeutics–LifeSci: public relations, 201801 service existent by LifeSci Advisors 2018-01-04
CureVac–Arcturus Therapeutics: mRNA therapeutics, 201801– strategic collab for lipid-mediated mRNA drugs using RNAoptimizer + LUNAR system 2018-01-04
Enterome–Principia SGR: investment, 201801 financing round Series D totalling €32m incl new investor Principia SGR 2018-01-04
Ahead Therapeutics–SEVERAL: investment, 2018 funding total private investment attracted Jan to May 2018 2018-01-01
Elma Care–SEVERAL: investment, 2018 funding total private investment attracted Jan to May 2018 2018-01-01
Mediquo–SEVERAL: investment, 2018 funding total private investment attracted Jan to May 2018 2018-01-01
Pontifax–SEVERAL: investment, 201710–201801 closing $240m of new fifth fund 2018-01-01
ProteoDesign–SEVERAL: investment, 2018 funding total private investment attracted Jan to May 2018 2018-01-01
BiomX–8VC: investment, 201712 investment €na by 8VC in connection with acquisition of RondinX by BiomX 2017-12-19
RondinX–BiomX: investment, 201712 acquisition €na of RondinX by BiomX 2017-12-19
Grifols–EU (govt): credit, 201712– loan €85m from European Investment Bank 2017-12-05
CLINGLIO project–EU (govt): grant, 201712–202011 Horizon 2020 grant €6.15m 3y for ph2 trial of 2OHOA in malignant glioma 2017-12-01
Mind the Byte–Prosilico: drug discovery + development software, 201711– collab co-promotion + product integration 2017-11-15
Zebra Medical Vision–Blonde 2.0: public relations, 201710 service existent by Blonde 2.0 2017-10-27
SurgVision–Bracco: investment, 201710 acquisition of SurgVision BV by Bracco Imaging SpA 2017-10-18
Weizmann Institute–Bruker Corp: MRI system, 201710 supply Biospec 15.2 Tesla USR preclinical UHF MRI system 2017-10-18
BIA Separations–Nuvonis: vaccine + gene therapy production technology, 201710– collab co-marketing of cell lines + purification technologies 2017-10-10
Arcturus Therapeutics–Alcobra: investment, 201709– reverse merger with Arcturus owners to own 60% of combined company to be renamed Arcturus 2017-09-27
BiondVax–SEVERAL: investment, 201709 Pulbic Offering $10m w 1.5m+166.7k ADSs at $6/ADS 2017-09-13
Genenta Science–SEVERAL: investment, 201709 financing round Series B €7m 2017-09-13
Mestrelab Research–SpectralWorks: analytical instrument software, 201708– collab mutual reseller agreem for all respective NMR/MS s/w products 2017-08-15
Eloxx Pharmaceuticals–Life Sciences Partners: investment, 201708 LSP invests $8m thereby closing + bringing total Series round to $38m 2017-08-02
Eloxx Pharmaceuticals–SEVERAL: investment, –201708 financing round Series C $38m from LSP + Pontifx + OPKO Health et al 2017-08-02
Axxam–Enamine: chemical compound libraries, 201708– supply expansion addit small molecule compounds for CNS research 2017-08-01
Kite Pharma–Pontifax: investment, –201708 Pontifax as one of first investors invested $3.8m yielding return of $130m w sale of Kite to Gilead 2017-08-01
DiaSorin–Siemens: ELISA immunoassays, 201707– acquisition up to €47.5m of Siemens ELISA Dx portfolio/assets without employees + mftg capacity 2017-07-25
NeuroDerm–Mitsubishi Chemical: investment, 201707– acquisition $1.1b in cash $39/share by Mitsubishi Tanabe Pharma Corp ANNOUNCED 2017-07-24
Boehringer–Philogen: drug discovery services, 201707– collab €na discovery + optimisation of small molecule drugs using ESAC technology 2017-07-20
BASF–Kaiima: plant biotechnology, 201707– collab research multi-year using EP technology to discover herbicide resistent traits 2017-07-17
GigaGen–Grifols: investment, acquisition of 44% stake in GigaGen Inc for $35m in cash by Grifols 2017-07-05
Mitoconix Bio–Arix Bioscience: investment, 201706 financing round Series A totalling $20m incl £0.4m from new + co-investor Arix Bioscience 2017-06-27
Mitoconix Bio–OrbiMed: investment, 201706 financing round Series A totalling $20m incl co-investor OrbiMed 2017-06-27
Mitoconix Bio–SEVERAL: investment, 201706 financing round Series A $20m led by Remiges Ventures + incl OrbiMed + Arix Bioscience + RMPG et al 2017-06-27
Genoma (IT)–Eurofins: investment, 201706 acquisition of Genoma Group Srl by Eurofins 2017-06-26
1 2 3 4 5 6 7  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top